 鲜花( 85)  鸡蛋( 2)
|

楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval/ U" Z7 Q* M" i7 o a
8 D* Y9 G+ B6 v. ^
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX., h9 _4 r- o" I. m5 B0 I) r
a, C V2 {7 I- K8 n+ }
BY THE EDMONTON JOURNAL FEBRUARY 16, 2007
: S' v8 [ Z4 z0 h6 Q* O& Z 7 M4 C$ W; k1 T, S! b J
2 y+ y) J. @$ M1 j8 ]6 q3 m; x! Q
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
* r7 m2 u8 G$ r# [* B4 O
% j8 }+ B( H: EThe agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."
( M; G, x5 F: m: W: k* D! t) q, _1 {& o) p- n$ V
The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product., R+ j, A0 u+ l
/ e4 c# c8 K q; I2 N6 \9 j7 J1 PIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.( j9 _/ B2 P, |+ [$ R7 @
7 ?: E- c1 E% P) A3 Q8 ]& LIt certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.. g; D& y+ x3 ~2 Q$ [' E
+ P I- C. _2 _1 J3 m; k
"As a scientist, it's one of the highlights of my CAREER," Shan said.
( Y, b, c5 a, m) [1 r; O7 g" d8 k3 s/ ~1 k& S& b- t# x
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."6 W" }9 M. q$ b8 ?* k
+ t1 U$ N( V" G- w9 NIt's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.' a+ R* X" f& l$ J
; ]- {) C# z S+ gGinseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.; F. U& |) ^; R/ I, a
8 }4 Z' L# S7 c Z' `The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.
8 ~4 ^- o% Q& {' x7 ]1 g, c% g8 A' A F; v) P; c- o
v, Z' Z1 q* g; U6 Dhttp://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|